BIOMAT Database Logo BIOMAT Database Logo

Acute hydrocortisone myopathy in acute severe asthma. 1986

A J Knox, and B H Mascie-Taylor, and M F Muers

UI MeSH Term Description Entries
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

A J Knox, and B H Mascie-Taylor, and M F Muers
Risk factors for hydrocortisone myopathy in acute severe asthma.
May 1990, Respiratory medicine,
A J Knox, and B H Mascie-Taylor, and M F Muers
Acute hydrocortisone myopathy.
July 1980, British medical journal,
A J Knox, and B H Mascie-Taylor, and M F Muers
High dose hydrocortisone therapy complicating acute severe asthma.
September 1995, The Journal of the Association of Physicians of India,
A J Knox, and B H Mascie-Taylor, and M F Muers
Myopathy in severe asthma.
August 1992, The American review of respiratory disease,
A J Knox, and B H Mascie-Taylor, and M F Muers
Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids.
February 1988, The American review of respiratory disease,
A J Knox, and B H Mascie-Taylor, and M F Muers
Relative efficacy of hydrocortisone and methylprednisolone in acute severe asthma.
November 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A J Knox, and B H Mascie-Taylor, and M F Muers
Relative efficacy of hydrocortisone and methylprednisolone in acute severe asthma.
March 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A J Knox, and B H Mascie-Taylor, and M F Muers
Acute necrotizing myopathy and acute renal failure in association with acute severe asthma.
December 1994, Anaesthesia and intensive care,
A J Knox, and B H Mascie-Taylor, and M F Muers
Comparative efficacy of dexamethasone versus hydrocortisone in severe acute pediatric asthma.
September 2007, Iranian journal of allergy, asthma, and immunology,
A J Knox, and B H Mascie-Taylor, and M F Muers
[Life threatening asthma associated to severe pneumonia and acute myopathy].
May 2001, Minerva anestesiologica,
Copied contents to your clipboard!